Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel W Miller

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Plos One|December 30, 2020
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burdenMcKayla J Riggs, Nan Lin, Chi Wang, et al.
JCO Precision Oncology|January 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor MalignanciesAllison L Swiecki-Sikora, Lydia Williams, Ning Li, et al.
Cancers|June 28, 2023
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology PracticeTaylor A Rives, Heather Pavlik, Ning Li, et al.
Women'S Health (London, England)|May 19, 2016
Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal womenJason R Lefringhouse, Erin Neward, Frederick R Ueland, et al.
Obstetrics and Gynecology|August 24, 2013
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonographyEdward J Pavlik, Frederick R Ueland, Rachel W Miller, et al.
Southern Medical Journal|January 4, 2020
Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health DisparitiesMarian Symmes Johnson, Thomas C Tucker, Quan Chen, et al.
Obstetrics and Gynecology|October 11, 2018
Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound ScreeningJohn R van Nagell, Brian T Burgess, Rachel W Miller, et al.
Obstetrics and Gynecology|August 24, 2012
Ten-year relative survival for epithelial ovarian cancerLauren A Baldwin, Bin Huang, Rachel W Miller, et al.
Biomedicines|August 27, 2021
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin ResistanceJustin W Gorski, Zhuwei Zhang, J Robert McCorkle, et al.
Diagnostics (Basel, Switzerland)|March 12, 2017
Complications from Surgeries Related to Ovarian Cancer ScreeningLauren A Baldwin, Edward J Pavlik, Emma Ueland, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Plos One|December 30, 2020
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burdenMcKayla J Riggs, Nan Lin, Chi Wang, et al.
JCO Precision Oncology|January 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor MalignanciesAllison L Swiecki-Sikora, Lydia Williams, Ning Li, et al.
Cancers|June 28, 2023
Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology PracticeTaylor A Rives, Heather Pavlik, Ning Li, et al.
Women'S Health (London, England)|May 19, 2016
Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal womenJason R Lefringhouse, Erin Neward, Frederick R Ueland, et al.
Obstetrics and Gynecology|August 24, 2013
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonographyEdward J Pavlik, Frederick R Ueland, Rachel W Miller, et al.
Southern Medical Journal|January 4, 2020
Uterine Corpus Malignancies in Appalachia Kentucky: Incidence, Survival, and Related Health DisparitiesMarian Symmes Johnson, Thomas C Tucker, Quan Chen, et al.
Obstetrics and Gynecology|October 11, 2018
Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound ScreeningJohn R van Nagell, Brian T Burgess, Rachel W Miller, et al.
Obstetrics and Gynecology|August 24, 2012
Ten-year relative survival for epithelial ovarian cancerLauren A Baldwin, Bin Huang, Rachel W Miller, et al.
Biomedicines|August 27, 2021
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin ResistanceJustin W Gorski, Zhuwei Zhang, J Robert McCorkle, et al.
Diagnostics (Basel, Switzerland)|March 12, 2017
Complications from Surgeries Related to Ovarian Cancer ScreeningLauren A Baldwin, Edward J Pavlik, Emma Ueland, et al.
Pageof 4